THC-Based Alzheimer's Trial In Puerto Rico: IGC Pharma Targets Underrepresented Hispanic Communities
THC-Based Alzheimer's Trial In Puerto Rico: IGC Pharma Targets Underrepresented Hispanic Communities
IGC Pharma, Inc. (IGC), a leading cannabinoid-based formulation developer, has expanded its Phase 2 clinical trial for IGC-AD1, a natural THC-based investigational drug for Alzheimer's disease, to the University of Puerto Rico network.
IGC Pharma, Inc. (IGC) 是领先的大麻素类配方开发商，已将其针对阿尔茨海默氏病的天然四氢大麻酚研究药物 IGC-AD1 的2期临床试验扩展到 波多黎各大学 网络。
IGC is dedicated to developing advanced cannabinoid-based formulations for a range of diseases, including Alzheimer's, dysmenorrhea, PMS and chronic pain.
IGC致力于开发先进的大麻素类配方，用于治疗一系列疾病，包括阿尔茨海默氏症、痛经、经前综合征和慢性疼痛。
Advanced Cannabinoid Therapies for Multiple Diseases
治疗多种疾病的高级大麻素疗法
"We are excited to announce our partnership with the University of Puerto Rico, a remarkable institution conducting world-leading medical research. The addition of this site with individuals living with Alzheimer's from the Hispanic community is a significant milestone in our Phase 2 trial. Alzheimer's disease, including the resulting symptom of agitation, is complex to treat and incredibly hard to live with," Ram Mukunda, CEO of IGC Pharma said in a press release.
“我们很高兴地宣布与波多黎各大学建立合作伙伴关系，波多黎各大学是一所从事世界领先医学研究的杰出机构。这个网站上有来自西班牙裔社区的阿尔茨海默氏症患者，这是我们2期试验的重要里程碑。阿尔茨海默氏病，包括由此产生的焦虑症状，治疗起来很复杂，而且很难忍受，” Ram Mukunda，IGC Pharma首席执行官在一份新闻稿中说。
"According to clinicaltrials.gov, IGC-AD1 is the only natural THC-based investigational drug undergoing FDA trials," per the release.
新闻稿称：“根据clinicaltrials.gov的数据，IGC-AD1 是唯一正在接受美国食品药品管理局试验的基于四氢大麻酚的天然研究药物。”
Their therapy, which involves low doses of THC and another compound, has shown promise in pre-clinical studies for improving Aβ plaques and reducing neuropsychiatric symptoms in Alzheimer's-related dementia.
他们的疗法涉及低剂量的四氢大麻酚和另一种化合物，在临床前研究中显示出改善Aβ斑块和减轻阿尔茨海默氏症相关痴呆症神经精神症状的前景。
Alzheimer's Trial Targets Hispanic Populations in Puerto Rico
阿尔茨海默氏症试验针对波多黎各的西班牙裔人群
The Phase 2 trial's expansion to Puerto Rico aims to increase population diversity and the representation of underrepresented groups.
第二阶段试验扩展到波多黎各，旨在增加人口多样性和代表性不足群体的代表性。
Dr. Vanessa Sepúlveda-Rivera, principal investigator for the University of Puerto Rico trial, emphasized the importance of including Hispanic populations in medical research, given the higher prevalence of Alzheimer's in Puerto Rico compared to the continental U.S. population.
Vanessa Sepu'lveda-Rivera 博士波多黎各大学试验的首席研究员强调了将西班牙裔人群纳入医学研究的重要性，因为与美国大陆人口相比，波多黎各的阿尔茨海默氏症患病率更高。
With plans to add sites in South America and Canada, the trial will enroll 146 patients, half of whom will receive IGC-AD1 and the other half a placebo.
该试验计划在南美和加拿大增加研究点，将招收146名患者，其中一半将接受 IGC-AD1，另一半将接受安慰剂。
The goal is to evaluate the drug's efficacy in reducing agitation, a symptom affecting 76% of Alzheimer's patients.
目标是评估该药物在减少躁动方面的功效，这种症状影响了76％的阿尔茨海默氏症患者。
IGC's Drug Trials and Products
IGC 的药物试验和产品
IGC has developed proprietary compounds, IGC-AD1 and TGR-63.
IGC 已经开发出专有化合物，即 IGC-AD1 和 TGR-63。
IGC-AD1, a low-dose THC-based formulation, is currently undergoing a Phase 2 clinical trial with the identifier NCT05543681 on clinicaltrials.gov.
IGC-AD1 是一种基于四氢大麻酚的低剂量配方，目前正在clinicaltrials.gov上进行标识符为 NCT05543681 的2期临床试验。
IGC also markets the wellness brand Holief, catering to women dealing with premenstrual syndrome and menstrual cramps.
IGC还推销健康品牌Holief，为患有经前期综合症和月经来潮的女性。
The Benzinga Cannabis Capital Conference, the place where deals get done, is returning to Chicago this Sept 27-28 for its 17th edition. Get your tickets today before prices increase and secure a spot at the epicenter of cannabis investment and branding.
Benzinga Cannabis Capital Conference是达成交易的地方，将于9月27日至28日重返芝加哥参加第17届会议。在价格上涨之前立即获取门票，并在大麻投资和品牌的中心占有一席之地。
Check the tickers below for instant updates on some of the best ETFs in cannabis.
查看下面的股票代码，了解大麻中一些最好的交易所买卖基金的即时更新。
- Cambria Cannabis ETF (BATS:TOKE)
- Amplify Seymour Cannabis ETF (NYSE:CNBS)
- AdvisorShares Pure Cannabis ETF (NYSE:YOLO)
- ETFMG Alternative Harvest (NYSE:MJ)
- AXS Cannabis ETF (NYSE:THCX)
- Global X Cannabis ETF (NASDAQ:POTX)
- 坎布里亚大麻ETF（BATS: TOKE）
- 放大西摩大麻ETF（纽约证券交易所代码：CNBS）
- AdvisorShares 纯大麻ETF（纽约证券交易所代码：YOLO）
- ETFMG 另类收获（纽约证券交易所代码：MJ）
- AXS Cannabis ETF（纽约证券交易所代码：THCX）
- Global X 大麻ETF（纳斯达克股票代码：POTX）
Image: Raman Oza via Pixabay.
图片：来自 Pixabay 的 Raman Oza。